KMC Speciality Hospitals (India) Limited (BOM:524520)
India · Delayed Price · Currency is INR 117.85
+1.00 (0.86%)
At close: Jun 17, 2026
BOM:524520 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 3,058 | 2,316 | 1,772 | 1,558 | 1,361 |
| 3,058 | 2,316 | 1,772 | 1,558 | 1,361 | |
Revenue Growth (YoY) | 32.03% | 30.72% | 13.75% | 14.46% | 32.58% |
Cost of Revenue | 1,108 | 952.29 | 688.08 | 585.69 | 524.46 |
Gross Profit | 1,949 | 1,364 | 1,084 | 971.87 | 836.27 |
Selling, General & Admin | - | 74.64 | 35.27 | 35.42 | 29.13 |
Other Operating Expenses | 1,070 | 716.76 | 566.32 | 517.64 | 432.11 |
Operating Expenses | 1,287 | 982.24 | 699.96 | 632.92 | 528.5 |
Operating Income | 662.55 | 381.45 | 383.71 | 338.95 | 307.77 |
Interest Expense | -83.07 | -94.16 | -11.64 | -8.11 | -6.96 |
Interest & Investment Income | - | 8.51 | 20.33 | 17.67 | 12.45 |
Other Non Operating Income (Expenses) | 50.76 | 20.12 | 13.38 | 12.32 | 7.43 |
EBT Excluding Unusual Items | 630.24 | 315.92 | 405.78 | 360.83 | 320.69 |
Gain (Loss) on Sale of Assets | - | 0.11 | -0.2 | -0.93 | 0.29 |
Pretax Income | 630.24 | 316.03 | 405.58 | 359.9 | 320.98 |
Income Tax Expense | 162.89 | 101.76 | 101.79 | 93.02 | 83.72 |
Net Income | 467.34 | 214.27 | 303.79 | 266.88 | 237.26 |
Net Income to Common | 467.34 | 214.27 | 303.79 | 266.88 | 237.26 |
Net Income Growth | 118.11% | -29.47% | 13.83% | 12.49% | 85.66% |
Shares Outstanding (Basic) | 163 | 163 | 163 | 163 | 163 |
Shares Outstanding (Diluted) | 163 | 163 | 163 | 163 | 163 |
Shares Change (YoY) | -0.15% | - | - | - | - |
EPS (Basic) | 2.87 | 1.31 | 1.86 | 1.64 | 1.45 |
EPS (Diluted) | 2.87 | 1.31 | 1.86 | 1.64 | 1.45 |
EPS Growth | 119.08% | -29.57% | 13.66% | 12.49% | 85.66% |
Free Cash Flow | 624.58 | -62.99 | -368.51 | -117.89 | 156.4 |
Free Cash Flow Per Share | 3.84 | -0.39 | -2.26 | -0.72 | 0.96 |
Gross Margin | 63.75% | 58.88% | 61.16% | 62.40% | 61.46% |
Operating Margin | 21.67% | 16.47% | 21.66% | 21.76% | 22.62% |
Profit Margin | 15.28% | 9.25% | 17.15% | 17.14% | 17.44% |
Free Cash Flow Margin | 20.43% | -2.72% | -20.80% | -7.57% | 11.49% |
EBITDA | 879.26 | 549.87 | 461.36 | 405.62 | 364 |
EBITDA Margin | 28.76% | 23.74% | 26.04% | 26.04% | 26.75% |
D&A For EBITDA | 216.71 | 168.42 | 77.65 | 66.67 | 56.24 |
EBIT | 662.55 | 381.45 | 383.71 | 338.95 | 307.77 |
EBIT Margin | 21.67% | 16.47% | 21.66% | 21.76% | 22.62% |
Effective Tax Rate | 25.85% | 32.20% | 25.10% | 25.85% | 26.08% |
Revenue as Reported | 3,108 | 2,347 | 1,807 | 1,589 | 1,382 |
Advertising Expenses | - | 57.84 | 28.85 | 27.4 | 22.35 |